Nynikka Palmer, DrPH, MPH

Borno HT, Zhang L, Zhang S, Kaplan C, Palmer NR, Bell A, Bakke B, Lin A, Aggarwal R, Small EJ. Mobile Clinical Trial Matching Technology in Medical Oncology Clinic: A Pilot Feasibility Study. 2022. PMID: 35584338

Hiatt RA, Sibley A, Venkatesh B, Cheng J, Dixit N, Fox R, Ling P, Nguyen T, Oh D, Palmer NR, Pasick RJ, Potter MB, Somsouk M, Vargas RA, Vijayaraghavan M, Ashworth A. From Cancer Epidemiology to Policy and Practice: the Role of a Comprehensive Cancer Center. 2022. PMID: 35342686

Esdaille AR, Ibilibor C, Ii AH, Palmer NR, Murphy AB. Access and Representation: A Narrative Review of the Disparities in Access to Clinical Trials and Precision Oncology in Black men with Prostate Cancer. 2021. PMID: 34582887

Samuel Washington, Peter Lonergan, Janet Cowan, Shoujun Zhao, Scott Greenberg, Jeanette Broering, Nynikka Palmer, Robert Parker, Alexander Bell, Matthew Cooperberg, Peter Carroll. MP19-14 LONGITUDINAL ANALYSIS OF THE INDIRECT BURDEN OF PROSTATE CANCER TREATMENT ON PAID AND UNPAID WORK: DATA FROM CAPSURE. 2021. PMID:

Bell A, Lonergan PE, Escobar D, Fakunle M, Chu CE, Berdy S, Palmer NR, Breyer BN, Washington SL. A cross-sectional analysis of barriers associated with non-attendance at a urology telehealth clinic in a safety-net hospital. 2021. PMID: 34461145

Palmer NR, Borno HT, Gregorich SE, Livaudais-Toman J, Kaplan CP. Prostate cancer patients' self-reported participation in research: an examination of racial/ethnic disparities. 2021. PMID: 34189651

Borno HT, Andemeskel G, Palmer NR. Redefining Attribution From Patient to Health System-How the Notion of "Mistrust" Places Blame on Black Patients. 2021. PMID: 33662096

Langlais CS, Graff RE, Van Blarigan EL, Palmer NR, Washington SL, Chan JM, Kenfield SA. Post-Diagnostic Dietary and Lifestyle Factors and Prostate Cancer Recurrence, Progression, and Mortality. 2021. PMID: 33689041

Elena Portacolone, Nynikka Palmer, Peter Lichtenberg, Catherine Waters, Carl Hill, Sahru Keiser, Julene K Johnson. Earning the Trust of African American Communities to Increase Representation in Dementia Research. 2020. PMID:

Portacolone E, Palmer NR, Lichtenberg P, Waters CM, Hill CV, Keiser S, Vest L, Maloof M, Tran T, Martinez P, Guerrero J, Johnson JK. Earning the Trust of African American Communities to Increase Representation in Dementia Research. 2020. PMID: 33250619

Balakrishnan AS, Palmer NR, Odisho AY. "Can you hear me now?": postoperative patient-initiated communication with providers. 2020. PMID: 33094946

Zavala VA, Bracci PM, Carethers JM, Carvajal-Carmona L, Coggins NB, Cruz-Correa MR, Davis M, de Smith AJ, Dutil J, Figueiredo JC, Fox R, Graves KD, Gomez SL, Llera A, Neuhausen SL, Newman L, Nguyen T, Palmer JR, Palmer NR, Pérez-Stable EJ, Piawah S, Rodriquez EJ, Sanabria-Salas MC, Schmit SL, Serrano-Gomez SJ, Stern MC, Weitzel J, Yang JJ, Zabaleta J, Ziv E, Fejerman L. Cancer health disparities in racial/ethnic minorities in the United States. 2020. PMID: 32901135

Palmer NR, Shim JK, Kaplan CP, Schillinger D, Blaschko SD, Breyer BN, Pasick RJ. Ethnographic investigation of patient-provider communication among African American men newly diagnosed with prostate cancer: a study protocol. 2020. PMID: 32759241

Palmer NR, Avis NE, Fino NF, Tooze JA, Weaver KE. Rural cancer survivors' health information needs post-treatment. 2020. PMID: 32147307

Kith G, Lisker S, Sarkar U, Barr-Walker J, Breyer BN, Palmer NR. Defining and Measuring Adherence in Observational Studies Assessing Outcomes of Real-world Active Surveillance for Prostate Cancer: A Systematic Review. 2019. PMID: 31288992

Balakrishnan AS, Palmer NR, Fergus KB, Gaither TW, Baradaran N, Ndoye M, Breyer BN. Minority Recruitment Trends in Phase III Prostate Cancer Clinical Trials (2003 to 2014): Progress and Critical Areas for Improvement. 2019. PMID: 30218761

Borno HT, Lichtensztajn DY, Gomez SL, Palmer NR, Ryan CJ. Differential use of medical versus surgical androgen deprivation therapy for patients with metastatic prostate cancer. 2018. PMID: 30444526

Kaplan CP, Siegel A, Leykin Y, Palmer NR, Borno H, Bielenberg J, Livaudais-Toman J, Ryan C, Small EJ. A bilingual, Internet-based, targeted advertising campaign for prostate cancer clinical trials: Assessing the feasibility, acceptability, and efficacy of a novel recruitment strategy. 2018. PMID: 30272035

Palmer NR, Gregorich SE, Livaudais-Toman J, Jih J, Kaplan CP. Racial and Ethnic Differences in Prostate Cancer Survivors' Perceived Engagement in Treatment Decision-Making. 2018. PMID: 29516434

Hiatt RA, Sibley A, Fejerman L, Glantz S, Nguyen T, Pasick R, Palmer N, Perkins A, Potter MB, Somsouk M, Vargas RA, van 't Veer LJ, Ashworth A. The San Francisco Cancer Initiative: A Community Effort To Reduce The Population Burden Of Cancer. Volume 37 of Issue 1. 2018. PMID: 29309234

Beebe-Dimmer JL, Yee C, Paskett E, Schwartz AG, Lane D, Palmer NRA, Bock CH, Nassir R, Simon MS. Family history of prostate and colorectal cancer and risk of colorectal cancer in the Women's health initiative. 2017. PMID: 29237415

Osterberg EC, Palmer NRA, Harris CR, Murphy GP, Blaschko SD, Chu C, Allen IE, Cooperberg MR, Carroll PR, Breyer BN. Outcomes of men on active surveillance for low-risk prostate cancer at a safety-net hospital. 2017. PMID: 28826701

E. Charles Osterberg, Nynikka Palmer, Catherine Harris, Gregory Murphy, Sarah Blaschko, Carissa Chu, Matthew Cooperberg, Peter Carroll, Benjamin Breyer. MP14-02 THE NATURAL HISTORY OF MEN ON ACTIVE SURVEILLANCE WITH LOW-RISK PROSTATE CANCER AT A SAFETY-NET, COUNTY HOSPITAL. 2017. PMID:

Palmer NR, Weaver KE, Hauser SP, Lawrence JA, Talton J, Case LD, Geiger AM. Disparities in barriers to follow-up care between African American and White breast cancer survivors. 2015. PMID: 25821145

Beebe-Dimmer JL, Yee C, Cote ML, Petrucelli N, Palmer N, Bock C, Lane D, Agalliu I, Stefanick ML, Simon MS. Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women's Health Initiative Study. 2015. PMID: 25754547

Palmer NR, Kent EE, Forsythe LP, Arora NK, Rowland JH, Aziz NM, Blanch-Hartigan D, Oakley-Girvan I, Hamilton AS, Weaver KE. Racial and ethnic disparities in patient-provider communication, quality-of-care ratings, and patient activation among long-term cancer survivors. 2014. PMID: 25403220

Palmer NR, Geiger AM, Lu L, Case LD, Weaver KE. Impact of rural residence on forgoing healthcare after cancer because of cost. 2013. PMID: 24097196

Palmer NR, Geiger AM, Felder TM, Lu L, Case LD, Weaver KE. Racial/Ethnic disparities in health care receipt among male cancer survivors. 2013. PMID: 23678936

Weaver KE, Palmer N, Lu L, Case LD, Geiger AM. Rural-urban differences in health behaviors and implications for health status among US cancer survivors. 2013. PMID: 23677333

Palmer NR, Bartholomew LK, McCurdy SA, Basen-Engquist KM, Naik AD. Transitioning from active treatment: colorectal cancer survivors' health promotion goals. 2012. PMID: 23089464

Palmer NR, Tooze JA, Turner AR, Xu J, Avis NE. African American prostate cancer survivors' treatment decision-making and quality of life. 2012. PMID: 22940374

Naik AD, Palmer N, Petersen NJ, Street RL, Rao R, Suarez-Almazor M, Haidet P. Comparative effectiveness of goal setting in diabetes mellitus group clinics: randomized clinical trial. 2011. PMID: 21403042

Felder TM, Palmer NR, Lal LS, Mullen PD. What is the evidence for pharmaceutical patient assistance programs? A systematic review. 2011. PMID: 21317504

McMahon CG, Stuckey BG, Lording DW, Wittert GA, Murphy A, Shin J, Sutherland PD, Palmer NR, Lowy MP, Jesudason DR, Fredlund P. A 6-month study of the efficacy and safety of tadalafil in the treatment of erectile dysfunction: a randomised, double-blind, parallel-group, placebo-controlled study in Australian men. 2005. PMID: 15854188